Form 4 for AXGN Axogen, Inc.
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-08 · accession 0000805928-25-000160 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-10 | 2025-12-08 | AXGN | Hartley Lindsey Marie | CFO | S - Sale+OE | $31.56 | -14.4K | 31.4K | -31% | -$454.1K |
| DM | 2025-12-10 | 2025-12-08 | AXGN | Hartley Lindsey Marie | CFO | M - OptEx | $13.82 | +25.0K | 40.8K | +159% | +$345.4K |
| DM | 2025-12-10 | 2025-12-08 | AXGN | Hartley Lindsey Marie | CFO | M - OptEx | $0.00 | -25.0K | 2,500 | -91% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-08 | S | D | 11,533 | $31.56 | 34,230 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-08 | M | A | 5,000 | $8.20 | 45,763 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-08 | M | A | 20,000 | $15.22 | 40,763 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-08 | S | D | 2,854 | $31.56 | 31,376 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right to purchase) | 2025-12-08 | M | D | 20,000 | $0.00 | 0 | D | $15.22 · — to 2031-11-01 | 20,000 Common Stock | (F1) All shares of Axogen, Inc. common stock underlying the employee stock option were fully vested on November 1, 2025 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on November 1, 2023 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter. |
| 6 | Derivative | Employee Stock Option (right to purchase) | 2025-12-08 | M | D | 5,000 | $0.00 | 2,500 | D | $8.20 · — to 2032-03-16 | 5,000 Common Stock | (F2) All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the option grant date) and an additional 12.5% of the aggregate shares have vested or will vest each 6 months thereafter. |